Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

Circulation, <a href=»https://www.ahajournals.org/toc/circ/145/25″>Volume 145, Issue 25</a>, Page 1875-1877, June 21, 2022.